Biocatalytic pHBA Production from Methanol via Shikimate Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing para-hydroxybenzoic acid (pHBA) from glucose in E. coli result in low titers, productivity, and yield, making them unsuitable for commercialization, and there is a need for a more efficient microbial system for its production.
Innovation Solution
A genetically engineered microorganism, such as Methylomicrobium alcaliphilum, is used to produce pHBA from C1 substrates like methanol and methane, incorporating a novel pathway with enzymes like chorismate pyruvate lyase, 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase, shikimate kinase, and 3-dehydroquinate dehydratase, optimized for enhanced expression and resistance to feedback inhibition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If pHBA is produced in E. coli from glucose, then production is achieved, but titer, productivity, and yield remain too low for commercialization
Solution Approach 1:
The patent changes the substrate parameter from glucose to C1 substrates (methane, methanol, formaldehyde, formate), and modifies the microbial host from E. coli to methylotrophic bacteria. This fundamental parameter change enables much higher pHBA titers (up to 150 g/L) and productivities (up to 5 g/L/h) while maintaining high carbon yields, resolving the contradiction between productivity and titer for commercial viability
Solution Approach 2:
The patent introduces exogenous shikimate pathway genes (aroG, aroL, aroD, ubiC) into methylotrophic bacteria that lack this pathway. By copying the essential aromatic amino acid biosynthesis genes from E. coli or other organisms into the methylotrophic host, the system enables de novo pHBA production from C1 substrates with high efficiency, achieving both high titer and productivity
2Ease of manufacture
If conventional sugar-based carbon sources are used for pHBA production, then biological production is achieved, but cost-effectiveness for commercialization is reduced
Solution Approach 1:
The patent changes the carbon source parameter from expensive sugar-based substrates to cheap and abundant C1 substrates (methane, methanol, formaldehyde, formate). Methylotrophic bacteria naturally utilize these C1 compounds as carbon and energy sources, enabling low-cost feedstock consumption. This parameter change makes pHBA production economically viable while maintaining high productivity through efficient C1 metabolism and engineered shikimate pathway
3Quantity of substance
If endogenous pHBA production in E. coli is utilized, then production occurs, but amounts are insufficient for commercial production
Solution Approach 1:
The patent copies the complete shikimate pathway gene set (aroG, aroL, aroD, ubiC) into methylotrophic bacteria that lack endogenous aromatic amino acid biosynthesis capability. This gene copying enables de novo pHBA production from C1 substrates with high efficiency. The engineered pathway directs carbon flux efficiently toward pHBA, achieving titers up to 150 g/L and productivities up to 5 g/L/h, vastly superior to endogenous E. coli production
Solution Approach 2:
The patent introduces chorismate pyruvate lyase (UbiC) as a key intermediary enzyme that catalyzes the committed step converting chorismate to pHBA. This intermediary enzyme acts as a bottleneck control point, directing metabolic flux away from aromatic amino acid synthesis and toward pHBA accumulation. The engineered UbiC expression level directly controls pHBA production rate and titer, enabling high-efficiency commercial production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered microorganism significantly increases the titer and yield of pHBA, making it commercially viable as a precursor for aromatic bioplastics and other industrially relevant chemicals.
Implementation Method 1
Biocatalytic production of para-hydroxybenzoic acid from methanol and methane
Implementation Method 2
culturing the recombinant microorganism in a fermentation broth
Data Source
AI summary
A method of producing para-hydroxybenzoic acid (pHBA) or a derivative thereof includes culturing the recombinant microorganism in a fermentation broth, wherein said recombinant microorganism comprising a genetically engineered pathway expressing at least one nucleic acid sequence encoding a polypeptide selected from: an exogenous chorismate pyruvate lyase of EC 5.4.4.2 or EC 4.1.3.40; an exogenous 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) synthase of EC 4.1.2.15, or EC 2.5.1.54; an exogenous shikimate kinase of EC 2.7.1.71; or an exogenous 3-dehydroquinate dehydratase (DHQ) of EC 4.2.1.10; adding a carbon source to the fermentation broth; and isolating the pHBA from the fermentation broth.